CNS Drugs Take Longer to Develop, Win Approval

September 19, 2018

Drugs targeting the central nervous system take significantly longer to develop and get approved than other meds, according to a new analysis. In fact, the report cites that CNS drugs took 20% longer to develop and about 19 months (36%) longer on average than other meds to win FDA approval after clinical trials. 

Previous Flipbook
Adverse Event Reporting: When TMI is Risky
Adverse Event Reporting: When TMI is Risky

Next Flipbook
Master Protocols Can Kickstart Clinical Trials
Master Protocols Can Kickstart Clinical Trials

Request a Genetics in Clinical Trials training session

What You'll Learn